AGEN - AGENUS INC
3.24
-0.150 -4.630%
Share volume: 257,048
Last Updated: 03-30-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$3.39
-0.15
-0.04%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-07-2024 | 08-08-2024 | 11-12-2024 | 03-17-2025 | 05-12-2025 | 08-11-2025 | 11-10-2025 | 03-16-2026 | |
| Assets | |||||||||
| Total Assets | 256.559 M | 292.415 M | 238.482 M | 226.271 M | 200.201 M | 185.221 M | 233.891 M | 226.798 M | |
| Current Assets | 60.352 M | 100.004 M | 50.154 M | 45.574 M | 23.138 M | 13.340 M | 133.950 M | 133.436 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 3.125 M | 3.355 M | 2.811 M | 2.415 M | 2.424 M | 1.760 M | 123.344 M | 122.643 M | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 6.263 M | 6.831 M | |
| Current Cash | 52.856 M | 93.723 M | 44.784 M | 40.437 M | 18.488 M | 9.534 M | 3.458 M | 2.998 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 30.482 M | 24.277 M | |
| Property Plant Equipment | 130.330 M | 127.569 M | 124.472 M | 120.087 M | 117.030 M | 112.722 M | 15.987 M | 15.470 M | |
| Other Assets | 65.877 M | 64.842 M | 63.856 M | 60.610 M | 60.033 M | 59.159 M | 83.954 M | 77.892 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 256.559 M | 292.415 M | 238.482 M | 226.271 M | 200.201 M | 185.221 M | 233.891 M | 226.798 M | |
| Total liabilities | 446.882 M | 513.254 M | 510.286 M | 532.695 M | 522.599 M | 521.529 M | 514.759 M | 504.659 M | |
| Total current liabilities | 256.002 M | 270.666 M | 270.644 M | 221.401 M | 208.304 M | 234.563 M | 287.132 M | 323.489 M | |
| Accounts Payable | 50.693 M | 50.843 M | 45.899 M | 61.470 M | 64.240 M | 74.396 M | 85.289 M | 82.987 M | |
| Other liabilities | 127.981 M | 185.659 M | 183.335 M | 225.127 M | 226.324 M | 209.278 M | 192.502 M | 169.919 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 30.473 M | 32.846 M | 23.151 M | 23.599 M | 0.000 | |
| Other liabilities | 127.981 M | 185.659 M | 183.335 M | 225.127 M | 226.324 M | 209.278 M | 192.502 M | 169.919 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -201.430 M | -241.311 M | -292.336 M | -326.380 M | -341.848 M | -354.601 M | -274.137 M | -271.111 M | |
| Common stock | 1.817 B | 1.830 B | 1.846 B | 1.858 B | 1.868 B | 1.883 B | 1.900 B | 1.912 B | |
| Retained earnings | -2.018 B | -2.071 B | -2.137 B | -2.183 B | -2.208 B | -2.236 B | -2.172 B | -2.183 B |